maXis II is THE market leading high-resolution LC-QTOF. This heralds a new era in QTOF technology with unprecedented performance across wide ranging applications to resolve the most demanding analytical challenges. 
 
A full range of specified performance parameters is delivered simultaneously. 
 
Bruker's Ultra-High Resolution QTOF (UHR) technology has reached new standards in accurate-mass LC-MSMS. In addition, the system offers Electron-Transfer Dissociation (ETD) capabilities for sequence analysis of intact proteins including monoclonal antibody subunits. 
 
Furthermore, native state samples, including antibody drug conjugates, can be measured at these enhanced performance levels (Native Mass Spectrometry). 
 
Let the maXis II achieve your goals in: 

Intact protein analysis and characterization of biopharmaceuticals 

Synthetic chemistry support 

Drug metabolite, degradant and impurity identification and quantitation 

Protein Conformational Studies by HDX-MS